Halftime Report Panelist

Crypto Analyst, CoinDesk
· tracked since Aug 2026
Calls
2
Win Rate
100.0%
return
+1.0%
Calls 2 1 Posts tracked · 1.0/day Posted today
Calls
7d 2
30d 2
90d 2
Best Calls
LLY Long +1.0%
VRTX Long +1.0%
Worst Calls
No live losers yet
Most Mentioned
LLY ×1
VRTX ×1
Recent Calls
VRTX Long 9 hours ago
LLY Long 9 hours ago
Win Rate 100% Long 2 Short 0
Win Rate
7d
30d
90d
Average Return +1.0% Long Return +1.0% Short Return -
Average Return
7d
30d
90d
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Aug 04
$1118.45
+1.0%
Cheap valuation, dominant obesity franchise growth.
Eli Lilly has cheapened from its peak (P/E down from 50x to low 30s), is expected to deliver >30% revenue growth and 50% growth in its dominant obesity platform, and upcoming drug approvals could catalyze further upside.
GLP-1 / Obesity
Long
Aug 04
$477.93
+1.0%
New purchase as healthcare allocation increases.
Vertex was just purchased as the healthcare weighting was increased to 11.7%, reflecting a conviction that healthcare exposure should continue to rise.
Pharma & Biotech
Showing 2 of 2 calls · sorted by mentions

Halftime Report Panelist has 2 trade ideas tracked on Buzzberg across 2 tickers since August 2026. Most covered: LLY, VRTX.